• Mashup Score: 0

    FRIDAY, Dec. 11, 2020 (HealthDay News) — A pair of studies shed new light on why a relatively rare blood cancer — acute myeloid leukemia (AML) — is more deadly among Black patients.The takeaways: Where patients live and their access to quality health care matter. And even when Black people with AML…

    Tweet Tweets with this article
    • A pair of studies shed light on why a relatively rare blood cancer - acute myeloid leukemia (AML) - is more deadly among Black patients. One showed that being Black is, in itself, a risk factor for worse outcomes from AML. @ASH_hematology @BhavanaBhatnag4 https://t.co/7EyzUdSQYv

  • Mashup Score: 1

    Dr. Bhavana Bhatnagar talks about how structural racism might contribute to poor survival outcomes in Black patients with acute myeloid leukemia.

    Tweet Tweets with this article
    • #ASH20 news from @NEJMGroup: Joe Elia interviews Dr. Bhavana Bhatnagar. She reports that African-American patients aged <60 with acute myeloid leukemia have lower 3-year survival compared with whites: 32% vs. 41%. https://t.co/ATjeD0QVPo @BhavanaBhatnag4 https://t.co/DUgJ2cgunS